• Home
  • DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.

Author List
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M
Publication
The oncologist
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366109470
Publication Year
2022
PubMed ID
35983951
Publication Title
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. Oncologist. 2022 11 03; 27(11):940-951.